Eczema Trial, Recruiting NCT06503510 Sponsor: Aalborg University Condition: Eczema
Back to Eczema

Eczema Trial, Recruiting

NCT06503510
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a man or woman in good general health
  • You are between 18 and 60 years old

Who may not be able to join:

  • You are currently pregnant or breastfeeding
  • You use cannabis, opioids, or any other recreational drugs
  • You have a current or past diagnosis of a neurological, skin, immune system, muscle or joint, heart, or mental health condition that could affect the results (such as nerve damage, muscle pain in the arms, anxiety, depression, or schizophrenia) (confirm with trial site)
  • You have moles, wounds, scars, or tattoos on the area of skin that would be examined or treated in the trial
  • You are currently taking medications that could affect the trial results, such as antihistamines (allergy medicines) or painkillers — antihistamines must be stopped at least 72 hours before the study, and any creams or moisturisers must be stopped at least 24 hours before
  • You currently use steroid medicines, either as tablets/injections or as creams applied to the skin
  • You have consumed alcohol or painkillers within 24 hours before a study day, or between study days
  • You have pain that is either ongoing or long-lasting
  • You have taken part in another clinical trial within the past week, or within the past four weeks if that trial involved a medication
  • You are not able to follow instructions or cooperate with the study team

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 21397785

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Aalborg University
Registry
ClinicalTrials.gov
Start date
6 January 2025
Est. completion
31 December 2025

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Measuring itch by computerized Visual Analog Scale Scoring; Measuring pain by computerized Visual Analog Scale Scoring; Superficial blood perfusion; Superficial blood perfusion; Wheal reaction; Average pruritis and pain numerical rating scale (NRS); Skin peak pain numerical rating scale (SPP-NRS); Peak pruritus numerical rating scale (PP-NRS); Mechanically evoked itch (MEI); Mechanically evoked itch (MEI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov